Which has higher immunization, hib3, South Asia (IDA & IBRD) or Turkey?

Turkey, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.

How many years of comparable data are there for South Asia (IDA & IBRD) and Turkey?

18 years are reported by both, from 2007 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

South Asia (IDA & IBRD) vs Turkey: Immunization, Hib3

South Asia (IDA & IBRD)

94.5%

in 2024

Turkey

99.0%

in 2024

South Asia (IDA & IBRD) rank

1st

Turkey rank

1st

Immunization, Hib3 over time

South Asia (IDA & IBRD)
Turkey

How they compare

Turkey currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.

Across all 18 years both countries report, Turkey has been ahead every year.

South Asia (IDA & IBRD) ranks 1st and Turkey ranks 1st of 43 groups.

Turkey has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	South Asia (IDA & IBRD)	Turkey	Difference	Ahead
2000s	3.6%	89.3%	85.7%	Turkey
2010s	50.6%	97.3%	46.7%	Turkey
2020s	90.6%	98.0%	7.4%	Turkey

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, South Asia (IDA & IBRD) or Turkey?: Turkey, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
What is the difference in immunization, hib3 between South Asia (IDA & IBRD) and Turkey?: 4.5%, with Turkey ahead.
How many years of comparable data are there for South Asia (IDA & IBRD) and Turkey?: 18 years are reported by both, from 2007 to 2024.
How do South Asia (IDA & IBRD) and Turkey rank globally for immunization, hib3?: South Asia (IDA & IBRD) ranks 1st and Turkey ranks 1st of 43 groups.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South Asia (IDA & IBRD) vs Turkey: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 17 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/south-asia-ida-and-ibrd/turkiye/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/south-asia-ida-and-ibrd/turkiye/">South Asia (IDA & IBRD) vs Turkey: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 17 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.